• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Food, Acid Supplementation and Drug Absorption - a Complicated Gastric Mix: a Randomized Control Trial.食物、酸补充剂和药物吸收——一个复杂的胃部混合体:一项随机对照试验。
Pharm Res. 2019 Sep 4;36(11):155. doi: 10.1007/s11095-019-2693-5.
2
Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria.雷贝拉唑诱导胃酸缺乏的健康志愿者使用盐酸甜菜碱进行胃再酸化。
Mol Pharm. 2013 Nov 4;10(11):4032-7. doi: 10.1021/mp4003738. Epub 2013 Sep 10.
3
Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.食物和雷尼替丁对健康志愿者中沙奎那韦药代动力学及胃内pH值的影响。
Pharmacotherapy. 2006 Aug;26(8):1060-8. doi: 10.1592/phco.26.8.1060.
4
Cisapride inhibits meal-stimulated gastric acid secretion and post-prandial gastric acidity in subjects with gastro-oesophageal reflux disease.西沙必利可抑制胃食管反流病患者进食刺激后的胃酸分泌及餐后胃酸度。
Aliment Pharmacol Ther. 2002 Oct;16(10):1819-29. doi: 10.1046/j.1365-2036.2002.01342.x.
5
The use of betaine HCl to enhance dasatinib absorption in healthy volunteers with rabeprazole-induced hypochlorhydria.使用盐酸甜菜碱增强雷贝拉唑诱导的胃酸过少的健康志愿者中达沙替尼的吸收。
AAPS J. 2014 Nov;16(6):1358-65. doi: 10.1208/s12248-014-9673-9. Epub 2014 Oct 2.
6
Meal Effects Confound Attempts to Counteract Rabeprazole-Induced Hypochlorhydria Decreases in Atazanavir Absorption.进餐效应混淆了抵消雷贝拉唑诱导的胃酸过少导致阿扎那韦吸收减少的尝试。
Pharm Res. 2017 Mar;34(3):619-628. doi: 10.1007/s11095-016-2090-2. Epub 2016 Dec 27.
7
Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.质子泵抑制剂:饭前服用比空腹服用能更好地抑制胃酸。
Aliment Pharmacol Ther. 2000 Oct;14(10):1267-72. doi: 10.1046/j.1365-2036.2000.00829.x.
8
The effects of a weakly acidic meal on gastric buffering and postprandial gastro-oesophageal reflux.弱酸性膳食对胃缓冲和餐后胃食管反流的影响。
Aliment Pharmacol Ther. 2011 Sep;34(5):568-75. doi: 10.1111/j.1365-2036.2011.04761.x. Epub 2011 Jul 5.
9
Intravenous esomeprazole (40 mg and 20 mg) inhibits gastric acid secretion as effectively as oral esomeprazole: results of two randomized clinical studies.静脉注射埃索美拉唑(40毫克和20毫克)抑制胃酸分泌的效果与口服埃索美拉唑相同:两项随机临床研究的结果。
Eur J Gastroenterol Hepatol. 2005 Feb;17(2):191-7. doi: 10.1097/00042737-200502000-00010.
10
Lack of effect of nizatidine-induced elevation of gastric pH on the oral bioavailability of dapsone in healthy volunteers.尼扎替丁引起的胃pH值升高对健康志愿者中氨苯砜口服生物利用度无影响。
Pharmacotherapy. 2002 Nov;22(11):1420-5. doi: 10.1592/phco.22.16.1420.33698.

引用本文的文献

1
Creating a Framework for Treating Autoimmune Gastritis-The Case for Replacing Lost Acid.创建治疗自身免疫性胃炎的框架——替代丢失酸的案例。
Nutrients. 2024 Feb 27;16(5):662. doi: 10.3390/nu16050662.

本文引用的文献

1
Meal Effects Confound Attempts to Counteract Rabeprazole-Induced Hypochlorhydria Decreases in Atazanavir Absorption.进餐效应混淆了抵消雷贝拉唑诱导的胃酸过少导致阿扎那韦吸收减少的尝试。
Pharm Res. 2017 Mar;34(3):619-628. doi: 10.1007/s11095-016-2090-2. Epub 2016 Dec 27.
2
Food, gastrointestinal pH, and models of oral drug absorption.食物、胃肠道pH值与口服药物吸收模型
Eur J Pharm Biopharm. 2017 Mar;112:234-248. doi: 10.1016/j.ejpb.2016.11.034. Epub 2016 Nov 30.
3
Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer.酸性饮料可乐对非小细胞肺癌患者厄洛替尼吸收的影响。
J Clin Oncol. 2016 Apr 20;34(12):1309-14. doi: 10.1200/JCO.2015.65.2560. Epub 2016 Feb 8.
4
Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.胃内pH值对健康个体中厄洛替尼药代动力学的影响:奥美拉唑和雷尼替丁。
Anticancer Drugs. 2015 Jun;26(5):565-72. doi: 10.1097/CAD.0000000000000212.
5
The use of betaine HCl to enhance dasatinib absorption in healthy volunteers with rabeprazole-induced hypochlorhydria.使用盐酸甜菜碱增强雷贝拉唑诱导的胃酸过少的健康志愿者中达沙替尼的吸收。
AAPS J. 2014 Nov;16(6):1358-65. doi: 10.1208/s12248-014-9673-9. Epub 2014 Oct 2.
6
pH-dependent drug-drug interactions for weak base drugs: potential implications for new drug development.基于 pH 值的弱碱性药物药物相互作用:对新药研发的潜在影响。
Clin Pharmacol Ther. 2014 Aug;96(2):266-77. doi: 10.1038/clpt.2014.87. Epub 2014 Apr 14.
7
Prevalence of acid-reducing agents (ARA) in cancer populations and ARA drug-drug interaction potential for molecular targeted agents in clinical development.癌症人群中抑酸剂(ARA)的患病率以及临床开发中分子靶向药物的ARA药物相互作用潜力。
Mol Pharm. 2013 Nov 4;10(11):4055-62. doi: 10.1021/mp400403s. Epub 2013 Oct 24.
8
Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria.雷贝拉唑诱导胃酸缺乏的健康志愿者使用盐酸甜菜碱进行胃再酸化。
Mol Pharm. 2013 Nov 4;10(11):4032-7. doi: 10.1021/mp4003738. Epub 2013 Sep 10.
9
Proton pump inhibitor prescriptions and subsequent use in US veterans diagnosed with gastroesophageal reflux disease.质子泵抑制剂处方及其在美国被诊断为胃食管反流病的退伍军人中的后续使用。
J Gen Intern Med. 2013 Jul;28(7):930-7. doi: 10.1007/s11606-013-2345-0.
10
Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?口服靶向抗癌药物与质子泵抑制剂之间的药物吸收相互作用:pH 依赖性溶解度是否是靶向治疗的阿喀琉斯之踵?
Clin Pharmacol Ther. 2012 Aug;92(2):203-13. doi: 10.1038/clpt.2012.73. Epub 2012 Jun 27.

食物、酸补充剂和药物吸收——一个复杂的胃部混合体:一项随机对照试验。

Food, Acid Supplementation and Drug Absorption - a Complicated Gastric Mix: a Randomized Control Trial.

机构信息

School of Pharmacy, University of California San Francisco, San Francisco, CA, USA.

School of Medicine, University of California San Francisco, San Francisco, CA, USA.

出版信息

Pharm Res. 2019 Sep 4;36(11):155. doi: 10.1007/s11095-019-2693-5.

DOI:10.1007/s11095-019-2693-5
PMID:31485804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7484952/
Abstract

PURPOSE

The purpose of this study was to determine the impact of food on gastric pH and the ability of over the counter betaine hydrochloride (BHCl) acid to reacidify gastric pH after food-induced elevations in gastric pH.

METHODS

This open-label cross over clinical study (NCT02758015) included 9 subjects who were randomly assigned to one of 16 possible, 4-period cross-over sequences to determine the impact and relationship of food and gastric pH with acid supplementation. Subjects were administered various doses (1500 mg, 3000 mg and 4500 mg) of betaine hydrochloride (BHCl) to determine the ability of acid supplementation to reacidify gastric pH after the elevation of gastric pH caused by the ingestion of food.

RESULTS

Following the administration of food and the resulting elevation in gastric pH, time to return to baseline gastric pH levels without acid supplementation was 49.7 ± 14.0 min. Administering 4500 mg of BHCl acid in capsules was able to reacidify gastric pH levels back to baseline following the administration of food in approximately 17.3 ± 5.9 min. AUC of each treatment were similar and not statistically different. Mean max pH following the administration of food was 3.20 ± 0.55.

CONCLUSION

The ability of food to elevate and maintain gastric pH levels in the presence of acid supplementation was made evident throughout the study. A 4500 mg dose of BHCl was required to reacidify gastric pH after the administration of food. This study details the difficulty faced by clinicians in dosing a poorly soluble, weakly basic drug to patients receiving acid reducing agents where administration with food is recommended to avoid gastric side effects.

TRIAL REGISTRATION

https://clinicaltrials.gov/ct2/show/NCT02758015.

摘要

目的

本研究旨在确定食物对胃 pH 值的影响,以及在食物引起胃 pH 值升高后,非处方盐酸甜菜碱(BHCl)酸重新酸化胃 pH 值的能力。

方法

这是一项开放标签的交叉临床试验研究(NCT02758015),纳入了 9 名受试者,他们被随机分配到 16 种可能的 4 期交叉序列中的 1 种,以确定食物和胃 pH 值与酸补充之间的影响和关系。受试者接受了不同剂量(1500mg、3000mg 和 4500mg)的盐酸甜菜碱(BHCl)补充剂,以确定在摄入食物引起胃 pH 值升高后,酸补充剂重新酸化胃 pH 值的能力。

结果

在给予食物并导致胃 pH 值升高后,不给予酸补充剂恢复到基线胃 pH 值水平的时间为 49.7±14.0 分钟。给予 4500mg 的 BHCl 酸胶囊能够在大约 17.3±5.9 分钟内使胃 pH 值水平恢复到基线。每种治疗方法的 AUC 相似,且无统计学差异。给予食物后的平均最大 pH 值为 3.20±0.55。

结论

在酸补充剂存在的情况下,食物升高和维持胃 pH 值的能力在整个研究中得到了证实。在给予食物后,需要给予 4500mg 的 BHCl 酸才能使胃 pH 值重新酸化。本研究详细说明了临床医生在给接受胃酸减少剂的患者用药时所面临的困难,因为建议与食物一起给药以避免胃副作用。

试验注册

https://clinicaltrials.gov/ct2/show/NCT02758015。